Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: To assess trends in occupational cancer epidemiology research through a literature review of occupational health and epidemiology journals.
Methods: Fifteen journals were reviewed from 1991 to 2009, and characteristics of articles that assessed the risk of cancer associated with an occupation, industry, or occupational exposure, were incorporated into a database.
Results: The number of occupational cancer epidemiology articles published annually declined in recent years (2003 onwards) in the journals reviewed. The number of articles presenting dose-response analyses increased over the review period, from 29% in the first 4 years of review to 49% in the last 4 years.
Conclusion: There has been a decrease in the number of occupational cancer epidemiology articles published annually during the review period. The results of these articles help determine the carcinogenicity of workplace exposures and permissible exposure limits, both of which may be hindered with a decline in research.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/ajim.22280 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
5'-Methylthioadenosine Metabolic Reprogramming Drives H3K79 Monomethylation-Mediated PAK2 Upregulation to Promote Cadmium-Induced Breast Cancer Progression by Impairing Autophagic Flux.
Adv Sci (Weinh)
September 2025
Department of Occupational Health (Key Laboratory of Electromagnetic Radiation Protection, Ministry of Education), Army Medical University (Third Military Medical University), Chongqing, 400038, China.
Cadmium (Cd) is a heavy metal that exhibits strong carcinogenic properties and promotes breast cancer (BC) progression. Autophagic flux dysfunction is involved in Cd-induced BC progression, but the underlying molecular mechanisms remain unclear. Here, it is observed that impaired autophagic flux and metabolic reprogramming are notable features related to Cd-induced proliferation, migration, and invasion in BC cell lines, including T-47D and MCF-7 cells.
View Article and Find Full Text PDFNew Indazole Derivatives as Potential Scaffolds for the Development of Anticancer, Antiviral, and Anti-tuberculosis Chemotherapeutic Compounds.
Curr Med Chem
September 2025
Laboratory of Molecular Basis of Action of physiologically active compounds, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991, Moscow, Russia.
Introduction: Chemotherapy remains essential despite advances in immunotherapy, radiotherapy, and biological therapy. However, the wide range of chemical drugs is limited by a narrow therapeutic index, low selectivity, and the development of resistance. In this regard, new high-efficiency drugs are in extremely high demand.
View Article and Find Full Text PDFA review of respirable crystalline silica dust concentration, characteristics, toxicity, and regulation in US metal and nonmetal mines.
J Hazard Mater
September 2025
Department of Mining Engineering, College of Engineering, University of Kentucky, Lexington, KY 40506, USA. Electronic address:
Occupational exposure to respirable crystalline silica (RCS) remains a significant health concern in metal and nonmetal (MNM) mining operations, contributing to the development of silicosis, lung cancer, and other chronic respiratory conditions. This review examines the prevalence and effects of RCS exposure in MNM mining environments, the toxicity of silica dust, and the effectiveness of regulatory interventions aimed at controlling exposure and mitigating health hazards. Key factors influencing RCS concentrations, including mine type, size, and geographic location, are analyzed, with particular focus on the impact of recent regulatory updates from the Mine Safety and Health Administration (MSHA).
View Article and Find Full Text PDFPrognostic factors of lenvatinib plus pembrolizumab therapy for advanced or recurrent endometrial cancer: analysis of a multicenter cohort study in Japan.
Int J Clin Oncol
September 2025
Department of Obstetrics and Gynecology, The University of Osaka Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Background: Lenvatinib plus pembrolizumab (LP) therapy has emerged as an effective treatment for patients with advanced or recurrent endometrial cancer. However, limited data are available regarding its outcomes in real-world settings. This study aimed to identify prognostic factors associated with the efficacy of LP therapy.
View Article and Find Full Text PDFCost-Efficiency of Risk-Based Lung Cancer Screening Across PLCOm2012 Risk Deciles.
J Thorac Oncol
September 2025
Department of Family and Community Medicine, Chung Shan Medical University Hospital, Institute of Medicine and School of Medicine, College of Medicine, Chung Shan Medical University, Taichung, Taiwan. Electronic address: